GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for CIDS

CIDS

Official Title

Canadian Implantable Defibrillator Study (CIDS)

Status

Completed

Overview

To evaluate Implantable Cardioverter Defibrillator against Amiodarone

Study Design

Randomized

Primary Endpoint

The primary outcome measure was all-cause mortality, and the secondary outcome was arrhythmic death.

Number of Patients

659

Number of Sites

24

Number of Countries

3

Study Period

1990–1997

Principal Investigator

Stuart Connolly

Program Manager

Not Applicable

Research Coordinator

Ellison Themeles

Key Publications

  • Connolly SJ1, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O’Brien B. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000 Mar 21;101(11):1297-302.